11 Jul 12
19 Jun 12
No, not the title of a new murder-mystery novel, but the facts of a case involving J Sainsbury PLC concerning the issue of “Vicarious Liability”. “Vicarious Liability” is the phrase used to describe the situation where a third party is responsible for acts committed, not by itself, but by another under its control.
13 Jun 12
The essential resource for implementing sustainable packaging labelling and artwork capabilities.
Stephen McIndoe and Andrew Love
12 Jun 12
A brag file is simply a file where you keep evidence of your achievements!
Mike Wood- Pharmiweb.com Portal Manager and Editor
12 Jun 12
A biologist’s job description may range widely depending on the area of specialty. A biologist is a scientist who studies life in one of its many forms, and a work settings can also range from a classical laboratory to field work in various environments and climates.
Online Biology Degree
06 Jun 12
Isogenica, Cresset and Biolauncher Secure £1M Funding to Develop New Small Molecule Drug Platform
30 May 12
“Need a degree to get a pay rise – don’t bother if you’re 61 or older!”
“Want to work beyond the age of 65 – afraid not, it’s in our Partnership Deed!”
These may sound like the worst job adverts in the world, but in fact they are the subject matter of two cases whose judgments were handed down by the Supreme Court last week (25 April 2012). These key cases are set to challenge employer’s attitude to age and retirement.
28 May 12
There has never been so much data in the world as there is now - how can pharmaceutical companies make sense of these increasing volumes of data, both for marketing and regulatory purposes? Stephen Dunnigan of business intelligence firm MicroStrategy looks at how technology can help unlock the potential of big data.
24 May 12
As both social media and webcasting continue to evolve at a rapid rate the pharmaceutical sector continues to innovate and evolve the ways in which it communicates to diverse and geographically spread audiences.
Jake Ward, Business Development Director, Groovy Gecko
22 May 12
Oncology products dominate the global therapeutics market, and are on course to reach an estimated €56 billion in sales by 2015. While cultural differences in approaches to
treatment and research into cancer undoubtedly exist between countries, investigators throughout the European Union have adopted similar approaches to the rigorous
evaluations of novel oncology treatments in Phase I clinical trials. But such trials are not conducted without reference to a number of considerations.
Jane Bentley, Ph.D., Vice President, Oncology Division, Novella Clinical
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.